Ricardo
Torres Peral
Profesor Asociado CC. Salud
Victor Manuel
Navas López
Publicaciones en las que colabora con Victor Manuel Navas López (7)
2024
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
-
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP
European Journal of Pediatrics
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2021
-
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study (European Journal of Pediatrics, (2021), 180, 9, (3029-3038), 10.1007/s00431-021-04063-6)
European Journal of Pediatrics
-
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
European Journal of Pediatrics, Vol. 180, Núm. 9, pp. 3029-3038
2020
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
2014
-
The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25years (1985-2009): The EXPERIENCE registry
Journal of Crohn's and Colitis, Vol. 8, Núm. 8, pp. 763-769